Inhibitory effect of radiotherapy combined with weekly recombinant human endostatin on the human pulmonary adenocarcinoma A549 xenografts in nude mice

Lung Cancer

Volumn 72, Issue 2, 2011, Pages 165-171

  Jiang, Xiao dong ^a,b   Dai, Peng ^b   Wu, Jin ^b   Song, Da an ^b   Yu, Jin ming ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b First People's Hospital of Lianyungang   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Pulmonary adenocarcinoma A549 cells; Radiotherapy; Recombinant human endostatin

Indexed keywords

RECOMBINANT ENDOSTATIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR REGRESSION; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ENDOSTATINS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; RADIOTHERAPY; RECOMBINANT PROTEINS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79953801590     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.09.003     Document Type: Article

References (19)

1. O'Reilly M.S. Radiation combined with antiangiogenic and antivascular agents. Semin Radiat Oncol 2006, 16:45-50.
2. Wen Q.L., Meng M.B., Yang B., Tu L.L., Jia L., Zhou L., et al. Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice. Cancer Sci 2009, 100:1510-1519.
3. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
4. Folkman J. Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res 2006, 312:594-607.
5. Jain R.K. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001, 7:987-989.
6. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
7. Winkler F., Kozin S.V., Tong R.T., Chae S.S., Booth M.F., Garkavtsev I., et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation. Angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004, 6:553-563.
8. Webb T. Vascular normalization: study examines how anti-angiogenesis therapies work. J Natl Cancer Inst 2005, 97:336-337.
9. Batchelor T.T., Sorensen A.G., di Tomaso E., Zhang W.T., Duda D.G., Cohen K.S., et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007, 11:83-95.
10. Folkman J. Tumor angiogenesis and tissue factor. Nat Med 1996, 2:167-168.
11. Abdollahi A., Hahnfeldt P., Maercker C., Gröne H.J., Debus J., Ansorge W., et al. Endostatin's antiangiogenic signaling network. Mol Cell 2004, 13:649-663.
12. Herbst R.S., Mullani N.A., Davis D.W., Hess K.R., McConkey D.J., Charnsangavej C., et al. Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. J Clin Oncol 2002, 20:3804-3814.
13. Dkhissi F., Lu H., Soria C., Opolon P., Griscelli F., Liu H., et al. Endostatin exhibits a direct antitumor effect in addition to its antiangiogentic activity in colon cancer cells. Hum Gene Ther 2003, 14:997-1008.
14. O'reilly, Kian Ang, Luka Milas, et al. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys 2007, 67:870-878.
15. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995, 47:9-19.
16. Gorski D.H., Beckett M.A., Jaskowiak N.T., Calvin D.P., Mauceri H.J., Salloum R.M., et al. Blockgae of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 1999, 9:3374-3378.
17. Koukourakis M.I., Giatromanolaki A., Sivridis E., Simopoulos K., Pissakas G., Gatter K.C., et al. Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy. Anticancer Res 2001, 21:4301-4309.
18. Kim Y.M., Jang J.W., Lee O.H., Yeon J., Choi E.Y., Kim K.W., et al. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res 2000, 60:5410-5413.
19. Cui R., Takahashi K., Takahashi F., Tanabe K.K., Fukuchi Y. Endostatin gene transfer in murine lung carcinoma resulting in up-regulation of in vivo tumorigenecity. Cancer Lett 2006, 232:262-271.